# Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca

> **NCT01555489** · PHASE2 · TERMINATED · sponsor: **Thomas Jefferson University** · enrollment: 11 (actual)

## Conditions studied

- Stage IV Pancreatic Cancer

## Interventions

- **DRUG:** Ascorbic Acid

## Key facts

- **NCT ID:** NCT01555489
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2025-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01555489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01555489, "Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01555489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*